SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
SEC Accession No. 0001104659-21-023985
Filing Date
2021-02-16
Accepted
2021-02-16 16:11:17
Documents
1
Group Members
KOH, BONGSHAH, NIMISHVHCP CO-INVESTMENT HOLDINGS III, LLCVHCP MANAGEMENT III, LLC

Document Format Files

Seq Description Document Type Size
1 SC 13G/A tm216523d8_sc13ga.htm SC 13G/A 114347
  Complete submission text file 0001104659-21-023985.txt   115973
Mailing Address 2488 DUNWIN DRIVE MISSISSAUGA A6 L5L 1J9
Business Address 2488 DUNWIN DRIVE MISSISSAUGA A6 L5L 1J9 (416) 595-0627
Trillium Therapeutics Inc. (Subject) CIK: 0001616212 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A6 | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-88719 | Film No.: 21638433
SIC: 2834 Pharmaceutical Preparations

Mailing Address 530 FIFTH AVENUE, 22ND FLOOR NEW YORK NY 10036
Business Address 530 FIFTH AVENUE, 22ND FLOOR NEW YORK NY 10036 212-444-4100
Venrock Healthcare Capital Partners III, L.P. (Filed by) CIK: 0001738048 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A